Growth Metrics

Ionis Pharmaceuticals (IONS) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Ionis Pharmaceuticals (IONS) over the last 9 years, with Q3 2025 value amounting to $363000.0.

  • Ionis Pharmaceuticals' Non Operating Income rose 15563.38% to $363000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1288.52%. This contributed to the annual value of $1.3 million for FY2024, which is 9057.94% down from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Non Operating Income is $363000.0, which was up 15563.38% from $102000.0 recorded in Q2 2025.
  • Ionis Pharmaceuticals' Non Operating Income's 5-year high stood at $11.2 million during Q2 2023, with a 5-year trough of -$12.3 million in Q2 2022.
  • Moreover, its 5-year median value for Non Operating Income was $277000.0 (2024), whereas its average is $1315.8.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 581677.85% in 2021, then soared by 613333.33% in 2022.
  • Ionis Pharmaceuticals' Non Operating Income (Quarter) stood at -$477000.0 in 2021, then skyrocketed by 236.06% to $649000.0 in 2022, then crashed by 38.52% to $399000.0 in 2023, then dropped by 21.3% to $314000.0 in 2024, then increased by 15.61% to $363000.0 in 2025.
  • Its Non Operating Income stands at $363000.0 for Q3 2025, versus $102000.0 for Q2 2025 and $465000.0 for Q1 2025.